期刊文献+

磷酸化P38 MAPK对帕金森病MPTP模型小鼠黑质caspase-3表达的影响 被引量:1

Effect of phosphorylated-P38 MAPK on caspase-3 expression in substantia nigra of the MPTP mouse model of Parkinson's disease
下载PDF
导出
摘要 目的研究磷酸化P38 MAPK在1-甲基-4-苯基-1,2,3,6四氢吡啶(MPTP)所致帕金森病(PD)模型小鼠中对黑质半胱氨酸蛋白酶-3(caspase-3)的调控作用。方法将小鼠随机分为MPTP模型组,腹腔注射MPTP(30mg/kg,生理盐水溶);抑制剂组,在注射MPTP前1h腹腔注射SB203580(10mg/kg,溶于5mg/mLDMSO)。均1次/d,连续5d;对照组,注射与模型组和抑制剂组等量生理盐水和DMSO。观察行为学、免疫组织化学和免疫蛋白印迹法观察黑质酪氨酸羟化酶(TH)、caspase-3和磷酸化P38 MAPK(p-P38MAPK)的表达。结果与对照组相比,模型小鼠出现典型的PD症状,TH阳性神经元和蛋白水平分别下降约60%和65%(P<0.01),p-P38 MAPK、caspase-3阳性细胞及蛋白水平显著增加(P<0.01);经P38 MAPK抑制剂SB203580处理后,上述变化均显著减轻(P<0.01)。结论磷酸化P38 MAPK在MPTP诱导的PD小鼠黑质caspase-3表达中可能有重要调控作用,SB203580对PD小鼠具有一定的神经保护作用。 Objective To investegate the effect of phosphorylated-P38 MAPK( mitogen-activated protein kinase) on the expression of caspase-3 in the substania nigra(SN) of MPTP-induced mouse model of(PD). Methods Mice were randomly divided into MPTP model group, which were treated with MPTP and inhibitor group. Once a day for 5 days; control group was treated with saline and DMSO as much as the model group received per day for 5 days. The behavioral were observed, immunohistochemistry and Western blot for TH, caspase-3 and phosphorylation of P38 MAPK were used to observe the change of positive cell number and the expression level in the SN of midbrain. Results Compared with the mice in control group, the model group showed typical symtoms of PD with decreased numbers of TH-positive neurons and the protein level of TH in SN of the midbrain by about 60% and 65% respectively(P 〈0.01 ) , the numbers of caspase-3 and phosphorytation of P38 MAPK immunoreactive cells and their protein level in the SN of the midbrain increased markedly (P 〈 0. 01 ). After giving SB203580, the above changes were reduced obviously (P 〈0.01 ). Conclusion In the mouse model of subaeute Parkinson's disease induced by MPTP, phosphorylated-P38 MAPK regulated easpase-3 in the SN of midbrain, the specific P38 MAPK inhibitor SB203580 is neurologically oprotective to the mouse model.
出处 《基础医学与临床》 CSCD 北大核心 2010年第1期54-58,共5页 Basic and Clinical Medicine
基金 河北省自然科学基金(C2004000689) 河北省博士基金(05547008D-4) 河北省科学技术与社会发展计划(04276135) 唐山市科学技术研究与发展计划(09130202A-3-19)
关键词 帕金森病 半胱氨酸蛋白酶-3 磷酸化P38 MAPK 酪氨酸羟化酶 1-甲基4-苯基-1 2 3 6-四氢吡啶 Parkinson's disease easpase-3 p-P38 MAPK TH MPTP
  • 相关文献

参考文献12

  • 1Schulz JB. Mechanisms of neurodegeneration in idiopathic Parkinson's disease[ J]. Parkinsonism Relat Disord, 2007, 13(3) :306 -308.
  • 2Beak S. Han, Hyun-seung Hong, Won-Seok Choi, et al. Caspase-dependent and independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment [ J]. J Neurosci, 2004, 23 (12) : 5069 - 5078.
  • 3Jiang Hong, Li Linjing, Wang Jun, et al. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra[ J]. Exp Neurol, 2008, 212 (2) :532 -537.
  • 4Roux PP, John B. Erk and P38 MAPK-aetivated protein kinases: a family of protein kinases with diverse biological functions [ J ]. Microbiol Mol Biol Rew, 2004, 68 ( 2 ) : 320 - 344.
  • 5Yamamoto N, Sawada H, Izumi Y, et al. Proteasome inhibition induces glutathione synthesis and pretects cells from oxidative stress[J]. ] Bil Chem, 2007, 282(7):4364- 4372.
  • 6Petroske E, Meredith GE, Callen S, et al. Mouse model of parkinsonism: a comparison between Subacte MPTP and chronic MPTP/PROBENECID treatment [ J ]. Neuroscience, 2001, 106(3 ) :589 - 601.
  • 7Smeyne RJ, Jackson-Lewis V. The MPTP model of Parkinson's disease [ J]. Brain Res Mol Brainres, 2005, 134( 1 ) :57 - 66.
  • 8谭玉燕,周海燕,陈生弟.帕金森病的细胞凋亡[J].中华老年医学杂志,2007,26(9):709-712. 被引量:5
  • 9Ikeda Y, Tsuji S, Satoh A, et al. Protective of effect of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells [ J ]. J Neurochem, 2008,107 (6) :1730 - 1740.
  • 10Corti O, Hampe C, Koutnikova H, et al. The p38 subunit of the aminoacyl-tRNA synthetase eompl-ex is a Parkin substrate:linking protein biosynthesis and neurodegeneration[J]. Hum Mol Genet, 2003,12(12) :1427 -1437.

二级参考文献14

  • 1Oleksandr E, Tak V. Apoptosis: key in neurodegenerative disorders. Curr Neurovas Res, 2004, 1:355-371.
  • 2Mogi M, Togari A, Kondo T, et al. Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the Substantia nigra from parkinsonian brain. J Neural Transm,2000, 107:335-341.
  • 3Jellinger KA. Cell death mechanisms in Parkinson' s disease. J Neural Transm, 2000, 107 : 1-29.
  • 4Cadet JL, Harrington B, Ordonez S, et al. Bcl-2 overexpression attenuates dopamine-induced apoptosis in an immortalized neural cell line by suppressing the production of reactive oxygen species. Synapse, 2000, 35:228-233.
  • 5Akiko Y, Yasuhiro Y, Kiyokazu O, et al. Involvement of endoplasmic reticulum stress on the cell death induced by 6-hydroxydopamine in human neuroblastoma SH-SY5Y cells. Neurochem Res, 2006, 31:657-664.
  • 6Yoshinaga N, Murayama T, Nomura Y, et al. Apoptosis induction by a dopaminergic neurotoxin, 1 methyl-4-phenylpyridiniunl ion ( MPP^+ ), and inhibition by epidermal growth factor in GH3 cells. Biochem Pharmacol,2000, 60:111-120.
  • 7Alves C, Julie D, Frederic B. 6 Hydroxydopamine but not 1-methyl 4-phenylpyridinium abolishes alphasynuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation. J Biol Chem, 2006, 281:9824-9831.
  • 8Dauer W, Kholodilov N, Vila M, et al. Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci USA,2002, 99: 14 524-14 529.
  • 9Machida Y, Chiba T, Takayanagi A, et al. Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells. Biochem Biophys Res Commun, 2005, 332:233-240.
  • 10Jiang H, Ren Y, Zhao J, et al. Parkin protects human dopaminergic neuroblastoma cells against dopamineinduced apoptosis. Hum Mol Genet, 2004, 13: 1745-1754.

共引文献4

同被引文献11

  • 1Van Cutsem E. The treatment of advanced gastric cancer:new findings on the activity of the taxanes[J].Oncologist(The),2004,(02):9-15.
  • 2Ajani J A. Evolving chemotherapy for advanced gastric cancer[J].Oncologist(The),2005,(03):49-58.
  • 3Efferth T,Dunstan H,Sauerbrey A. The anti-malarial artesunate is also active against cancer[J].International Journal of Oncology,2001,(04):767-773.
  • 4Ji-Hui Du,Hou-De Zhang,Zhen-Jian Ma. Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo[J].Cancer Chemotherapy and Pharmacology,2010,(05):895-902.
  • 5Wang Ma,Ming Gao,Wei He. Oxaliplatin and teniposide can inhibit the proliferation and induce the apoptosis of gastric cancer cell line BGC-823 synergistically[J].Chinese-German Journal of Clinical Oncology,2010,(03):149-152.doi:10.1007/s10330-009-0190-8.
  • 6Jiang Jiang-De,Jia Su-Jie,Dai Zhong. Asymmetric dimethylarginine induces apoptosis via p38 MAPK /Caspase-3 -dependent signaling pathway in endothelial cell s[J].Journal of Molecular and Cellular Cardiology,2006,(04):529-539.
  • 7Mu D,Zhang W,Chu D. The role of calcium,P38 MAPK in dihydroartemisinin induced apoptosis of lung cancer PC-14 cells[J].Cancer Chemotherapy and Pharmacology,2008,(04):639-645.
  • 8郭建红,丘明建.青蒿素类衍生物抗肿瘤研究进展[J].中国现代药物应用,2008,2(1):123-125. 被引量:5
  • 9谢晨曦,任建林.P38 MAPK信号传导通路与胃癌关系的研究现状[J].世界华人消化杂志,2008,16(30):3427-3432. 被引量:9
  • 10崔瑞雪,王贵吉,申凤乾,高伟艳,裴迎新.大蒜素联合奥沙利铂对HCT-8细胞生长和增殖的影响及机制[J].山东医药,2009,49(7):10-12. 被引量:6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部